About us:
HepatitisWA (Inc) is a non-profit community-based organisation providing free services to the community. HepatitisWA aims to assist in obtaining the best possible care and support for people affected by hepatitis, reducing discrimination and stigma directed at people living with viral hepatitis and raising community awareness in relation to hepatitis.
Our services include:
Support services for people who are affected by hepatitis by providing advice and support on living well with hepatitis, treatment options, managing treatments and referral. Support staff can be accessed by telephone, e-mail or face to face meetings by appointment. Peer support can be arranged. Contact 92279806 for more information.
The Hepatitis Helpline is available to every member of the community by contacting 93288538 (Metro) or 1800 800 070 (Country)
Community development in the form of:
The purpose of HepatitisWA is to respond effectively to the needs of people affected by hepatitis, and to enhance community awareness, health and wellbeing through information dissemination, education, support and advocacy in relation to hepatitis.
Vision:
To provide leadership in developing a world where people affected by hepatitis are able to maximize their health and wellbeing; and where hepatitis will be eliminated.
Aims:
Minimise the personal and social impact for people affected by hepatitis.
Provide an information service about viral hepatitis.
Assist in preventing the transmission of hepatitis.
Promote community awareness of hepatitis.
Contribute to community, state and national hepatitis prevention initiatives.
Influence public health policy and practice, and law in relation to hepatitis.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close